the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Iran aims to rekindle diplomatic ties with Egypt after 40-year rift

BERLIN: After more than 40 years of strained relations, Iran is hopeful for a resumption of diplomatic ties with its political rival, Egypt.

“Talks have been promising thus far, and both countries are on a good path to overcome their differences and to soon open a new diplomatic chapter,“ Iranian Foreign Ministry spokesman Nasser Kanaani said on Monday, German news agency (dpa) quoted the Tasnim news agency report in Tehran.

The re-establishment of relations would benefit not only the two nations, but also the Islamic world, and in particular Palestinians amid the current Gaza Strip conflict, Kanaani said.

Iranian President Ebrahim Raisi and his Egyptian counterpart Abdel-Fattah al-Sissi met for the first time in November on the sidelines of an Islamic summit in the Saudi capital, Riyadh.

According to Iranian media reports, the two presidents agreed on an action plan to resolve past differences and facilitate a warming of relations.

The two spoke by phone last week to discuss the latest developments in the Gaza Strip and the plan of action, the Iranian presidential office reported.

Relations between Tehran and Cairo have been tense over the past four decades.

The last Shah of Iran, Mohammad Reza Pahlavi, who was exiled in the 1979 Islamic Revolution, died in Egypt the following year and is buried in Cairo.

While the two countries have kept diplomatic channels open in recent years, they have not exchanged ambassadors.–Bernama-dpa

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings